StockWatch
·

Addus HomeCare Corp Q1 FY26 Results

ADUSQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue363.617.7%
Total Income363.617.7%
Expenditure329.547.3%
PBT32.4320.1%
Net Profit25.0718.1%
OPM9.37%0.33pp
NPM6.89%0.61pp
EPS1.3816.9%
View full financials

Addus HomeCare Announces Q1 2026 Financial Results with Revenue Up 7.7% to $363.6 Million

05 May 2026 · 5 May, 1:53 am

Summary

Addus HomeCare Corporation reported a strong start to 2026, with first-quarter net service revenues increasing 7.7% year-over-year to $363.6 million. Net income for the quarter grew to $25.1 million, or $1.36 per diluted share, while Adjusted EBITDA saw a 9.7% rise to $44.5 million. The company's personal care and hospice segments were key drivers of organic growth, benefiting from increased volumes and rate support in key states. Management highlighted continued demand for home-based care services, stable hiring trends, and a strong balance sheet supporting strategic investments and further acquisition opportunities, including a recent entry into the Indiana market.

Key Highlights

  1. 1

    Net service revenues for the first quarter of 2026 increased by 7.7% year-over-year to $363.6 million.

  2. 2

    Net income for Q1 2026 rose to $25.1 million, or $1.36 per diluted share, compared to $21.2 million, or $1.16 per diluted share, in the prior-year period.

  3. 3

    Adjusted Net Income per Diluted Share saw a 14.1% increase year-over-year, reaching $1.62 for the first quarter of 2026.

  4. 4

    Adjusted EBITDA grew by 9.7% year-over-year to $44.5 million for the first quarter of 2026.

  5. 5

    Cash flow from operations significantly increased to $52.4 million in Q1 2026, up from $18.9 million in Q1 2025.

  6. 6

    The company announced the acquisition of personal care operations in Indiana and an agreement for an additional Indiana acquisition, marking entry into a new market.

  7. 7

    The personal care business, representing 77.3% of revenues, achieved a 6.5% organic revenue increase, while the hospice care business grew organically by 7.7%.

Management Comments

D

Dirk Allison

Addus had a solid start to 2026, delivering an improved year-over-year financial and operating performance with revenue up 7.7% and adjusted EBITDA up 9.7% over the first quarter last year. These results reflect continued demand for our home-based care services across the continuum. Addus is well positioned to meet this demand as we continue to expand our market reach and add density in the states where we operate. Our hiring trends have been stable and consistent in the first quarter despite some brief winter weather interruptions in January. We are proud of the dedicated caregivers who represent Addus and continue to provide outstanding care and support to the patients and families who rely on us for quality care in their preferred home setting. Our personal care business, which accounted for 77.3% of our revenues, was the primary driver of our growth with a 6.5% organic revenue increase over the first quarter last year. We benefitted from higher volumes as well as additional rate support from two key states, including a 9.9% increase in Texas that was effective September 1, 2025, and a 3.9% increase from the State of Illinois that was effective beginning January 1, 2026. We are pleased that our strong value proposition as a cost-effective provider is being recognized by the states where we serve clients. Our hospice care business has performed well and accounted for 18.1% of our revenue for the first quarter. We have seen consistent trends in our hospice segment, resulting in 7.7% organic revenue growth over the first quarter of last year and year-over-year improvement in average daily census. Our home health business represented 4.6% of revenue for the first quarter. We believe home health provides important complementary capabilities and clinical collaboration for our personal care and hospice care segments as we see more patients in select markets receive the benefit of the full continuum of care. We are excited to announce this acquisition, which marks our entry into Indiana, a new market for Addus and our plans to further grow in the state. Acquisitions remain an integral part of our growth strategy, and we are pleased to welcome HomeCourt Home Care to our personal care operations. This transaction and our planned additional transaction are aligned with our strategy of expanding our personal care footprint in select markets and creating density in markets where we operate. We expect the HomeCourt transaction to be immediately accretive to our financial results. We look forward to further expanding our coverage and capabilities in Indiana. For the first quarter of 2026, we continued to generate consistent cash flow from operations and maintain a strong balance sheet. Our conservative leverage position allows us flexibility to make strategic investments in our business and to evaluate and pursue additional acquisition opportunities like those announced today. We have a strong development team with a proven track record, and we will continue our disciplined approach focused on both non-clinical and clinical acquisition opportunities where we can increase both density and geographic coverage. We see important synergies in offering the full care continuum as we build scale and expand our market coverage, and we are optimistic that we will see additional acquisition opportunities in 2026. We are pleased with the favorable trends in our business and believe we have significant opportunities in 2026 for continued organic growth and for deriving additional value from acquired operations. Addus plays an important role in our nation’s health care delivery system as a leading provider of quality, cost-effective care in the preferred home setting. We have a dedicated team of caregivers who work tirelessly every day to provide outstanding care across our markets. We look forward to the opportunities ahead for Addus in 2026 to deliver value to the clients we serve and our shareholders.

Informational and educational content only. Not investment advice.